Search

Displaying results 7661 - 7670 of 10000 in total
  1. Drug

    FCX-013

    go.drugbank.com/drugs/DB18218
    Investigational

    FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).

  2. Drug

    CKD-504

    go.drugbank.com/drugs/DB18235
    Investigational

    CKD-504 is a novel, selective histone deacetylase 6 inhibitor.

  3. Drug

    DR-01

    go.drugbank.com/drugs/DB18258
    Investigational

    DR-01 is a monoclonal antibody directed against human CD94.

  4. Drug

    MPB-1523

    go.drugbank.com/drugs/DB18334
    Investigational

    MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.[L48161]

  5. Drug

    CN-105

    go.drugbank.com/drugs/DB18345
    Investigational

    CN-105 is a neuroprotective pentapeptide with the sequence Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2).

  6. Drug

    NXC680

    go.drugbank.com/drugs/DB18366
    Experimental

    NXC680 is a small molecule under investigation for the treatment of idiopathic pulmonary fibrosis (IPF).

  7. Drug

    Zafiride

    go.drugbank.com/drugs/DB18371
    Investigational

    Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.

  8. Drug

    Sigvotatug Vedotin

    go.drugbank.com/drugs/DB18377
    Investigational

    Sigvotatug vedotin (SGN-B6A) is a humanized immunoglobulin G1 anti-integrin beta-6 monoclonal antibody conjugated to monomethyl auristatin E.

  9. Drug

    CALY-002

    go.drugbank.com/drugs/DB18378
    Investigational

    CALY-002 is a humanized monoclonal antibody targeting interleukin-15.

  10. Drug

    ART5803

    go.drugbank.com/drugs/DB18379
    Investigational

    ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.